Stock·NASDAQ·Technology
AST SpaceMobile Inc. (ASTS)
- Market cap
- $14.36B
- P/E
- n/m
- Dividend yield
- No dividend
- Street target
- $78.00median of 13 analysts
- 52-week range
- $27.58 $133.86
ASTS stock forecast today
Where ASTS stands today, and what CleaRank Financial AI makes of it.
ASTS at a glance
AST SpaceMobile Inc. (ASTS): Sell, 30/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($51.23 and $74.87).
- Earnings ASTS beat estimates in 2 of the 8 reports in our data, yet fell in the first session after both of them.
- Insiders Insiders sold $459.4M and bought $806K over the last 18 months.
Figures as of November 10, 2026.
CleaRank Financial AI
CleaRank rates AST SpaceMobile Inc. (ASTS) Sell, with a model score of 30/100.
Revenue growth lifts the score most: revenue grew 187.10%, 162.9 percentage points faster than the sector median. The trend holds it back most: the price is 55.03% below its 200-day average and 34.28% below its 50-day average, and the 50-day average is 31.57% below the 200-day. The 50-day average stands at $51.23 and the 200-day at $74.87. Over the past year the price fell 50.99%.
Only on CleaRank
Figures we compute ourselves from ASTS's own price, earnings and insider-filing history. Tap one to see it in context.
ASTS stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price below its 50-day average ›
The price of $33.67 is 34.3% below the 50-day simple moving average of $51.23.Price below its 200-day average ›
The price is 55.0% below the 200-day simple moving average of $74.87.50-day average below the 200-day ›
The 50-day average ($51.23) is 31.6% below the 200-day average ($74.87), the arrangement of a falling longer-term trend.In the lower half of its 52-week range ›
The price sits at 6% of its 52-week range, between $27.58 and $133.86.
ASTS share price
Pick a period: each tab shows how far ASTS has moved over it, to the last close.
Today's trading
Where ASTS sits inside today's range and its 52-week range.
ASTS fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
0/3P/S above the sector median ›
The price-to-sales ratio of 100.48 is 1,222.1% above the sector median of 7.6.Not profitable over the last 12 months ›
Net income over the last 12 months was -$628.3M on revenue of $142.9M, a net margin of -439.7%.Beat estimates in half or fewer of recent reports ›
ASTS beat the EPS estimate in 2 of the 8 reports in our data.
Key statistics
The headline figures for ASTS.
As of November 10, 2026, ASTS trades at $33.67, with a market value of $14.36B and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of ASTS's valuation, growth and risks.
ASTS has no meaningful P/E, because its earnings per share over the last 12 months are negative, which is why the ratio is not meaningful. Looking at sales instead, its P/S of 100.48 is 1,222.1% above the sector median P/S of 7.6. To put the size in context, the company has a market value of $14.4B and trailing earnings of -$2.13 per share.
The company is losing money, with a net margin of -439.72% and an operating margin of -398.52%, and a return on equity of -43.23%, below the sector median of 13.4%. In the latest quarter, against the same quarter a year earlier, revenue grew 187.10%, 162.9 percentage points faster than the sector median of 24.2%. Debt-to-equity of 1.90 rounds out the fundamentals.
ASTS reported EPS of -$0.44 in its latest report on November 9, 2026, beating the estimate of -$0.45 and landing above what analysts expected. Even so, the stock dropped 8.73% in the first session after the release.
The earnings record shows 2 beats in 8 reports, yet the stock fell in the first session after every one of those 2 beats. The consensus EPS estimate stands at -$2.29 for this fiscal year and -$1.28 for next.
ASTS typically moves about 6.61% in a day. While the price stays beneath both moving averages, the downtrend remains a risk in its own right. The price is 74.85% below its 52-week high of $133.86. Insiders sold $459.4M of stock over the last 18 months and bought $806K. Insider sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than open-market buying.
ASTS against the Technology sector
How ASTS compares with the median Technology stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, ASTS trades at 100.48x, far above the sector median of 7.60x.
Return vs XLK: Since May 29, 2025, ASTS has gained 56.5% against a gain of 47.6% for XLK.
Performance against XLK
ASTS and the Technology sector fund over the same days.
Revenue and earnings
How much ASTS sells, and how much of it becomes profit.
The quarterly bars end with Q1 '26 (the quarter to March 31, 2026); ASTS reported again on November 9, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue rose in FY2025 to $70.9M, from $4.4M a year earlier.
Profit margin: The net margin was -650.1% in FY2025, up from -11,913.3% the year before.
Loss-making: ASTS lost $461M in FY2025.
Earnings reality check
Did ASTS beat what analysts expected, and how did the stock react?
Earnings record: ASTS beat the analyst estimate in 2 of the 8 reports in our data.
Market reaction: The stock fell in the first session after 2 of those 2 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Nov 9, 2026 | -$0.45 | -$0.44 | +2.22% | -8.73% | - |
| Aug 10, 2026 | -$0.33 | -$0.77 | -133.33% | +4.17% | +3.46% |
| May 11, 2026 | -$0.20 | -$0.66 | -230.00% | -11.62% | +5.18% |
| Mar 2, 2026 | -$0.20 | -$0.26 | -30.00% | +6.63% | +3.27% |
| Aug 11, 2025 | -$0.22 | -$0.41 | -86.36% | +8.36% | +4.88% |
| May 12, 2025 | -$0.22 | -$0.20 | +9.09% | -2.25% | -9.39% |
| Mar 3, 2025 | -$0.18 | -$0.18 | +0.00% | +11.67% | +13.74% |
| Nov 14, 2024 | -$0.20 | -$1.10 | -450.00% | -9.59% | -9.93% |
As of November 10, 2026, ASTS has beaten the analyst EPS estimate in 2 of the 8 reports in our data and fell in the first trading session after 2 of those beats; its latest report, on November 9, 2026, came in 2.22% above the estimate and the stock moved -8.73% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
ASTS AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 36.1, showing bearish momentum without being oversold.RSI below 50 ›
An RSI of 36.1 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line below zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of ASTS
The score, the reasoning behind it, and what could move the price next.
Both moving averages sit above the price, the shape of a downtrend for ASTS: the price of $33.67 is 34.28% below the 50-day average ($51.23) and 55.03% below the 200-day average ($74.87). At 6% of its 52-week range, the price is 22.08% above the 52-week low of $27.58. The 50-day average runs 31.57% below the 200-day average, so the shorter trend is weaker than the longer one.
On momentum, the 14-day RSI reads 36.1, in the bearish zone, above the oversold line, with the MACD line negative. The recent returns all show a loss, with the price down 52.99% over the past three months, 53.85% over the past six months and 50.99% over the past year.
Analyst upgrade ›
Scotiabank upgraded it to Sector Outperform from Sector Perform on October 23, 2026.
Source: Analyst action, Scotiabank, October 23, 2026
Analyst downgrade ›
Piper Sandler downgraded it to Neutral from Overweight on October 13, 2026.
Source: Analyst action, Piper Sandler, October 13, 2026
Earnings beat, but the stock fell ›
The November 9, 2026 report beat the EPS estimate by 2.22%, and the share price fell 8.73% in the first session after it.
Source: Earnings report, November 9, 2026
- The two nearest levels matter most: the 20-day EMA at $40.04 above the price and the 52-week low at $27.58 below it.
- The 14-day RSI reads 36.1, in the bearish zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- The share price fell 8.73% in the first session after the November 9, 2026 report. ASTS has beaten estimates in 2 of the 8 reports in our data.
The downtrend stays in place while ASTS is below both its 50-day average at $51.23 and its 200-day average at $74.87; a close back above the 50-day would be the first step of a repair. The 20-day EMA at $40.04 is the first hurdle overhead.
The next level below the price is the 52-week low at $27.58.
Technical indicators
Momentum and trend for ASTS, from its daily closes.
As of November 10, 2026, with ASTS at $33.67, its 14-day RSI is 36.1 (showing bearish momentum without being oversold), its 50-day simple moving average is $51.23 and its 200-day is $74.87.
Calculated by CleaRank on daily closes as of November 10, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What ASTS moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of November 10, 2026, ASTS's 1-year correlation of daily returns is +0.42 with S&P 500 (SPY), +0.47 with Nasdaq 100 (QQQ), +0.31 with Bitcoin (BTC) and +0.17 with gold (XAU).
ASTS price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Half or fewer of analysts rate it a buy ›
5 of 13 analysts rate it a buy or strong buy, 6 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $78.00 is 131.7% above the price.Larger share of buy ratings than three months ago ›
5 of 13 rate it a buy now, against 4 of 13 three months ago.
ASTS Wall Street View
12-month price targets
The price, $33.67, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 23, 2026 | Scotiabank | Upgrade | Sector Outperform |
| Oct 13, 2026 | Piper Sandler | Downgrade | Neutral |
| Oct 12, 2026 | Deutsche Bank | Upgrade | Buy |
| Oct 2, 2026 | B. Riley Securities | Downgrade | Neutral |
| Sep 2, 2026 | Berenberg | Initiates | Buy |
| Aug 11, 2026 | UBS | Maintains | Neutral |
As of November 10, 2026, 13 Wall Street analysts cover ASTS: 5 rate it a buy or strong buy, 6 a hold and 2 a sell or strong sell. Their 12-month price targets range from $42.50 to $108.00. The median ASTS price target is $78.00, 131.7% above the price of $33.67.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
ASTS risk and volatility
How much it moves day to day, and how it stacks up against similar assets.
Risk profile
How much ASTS tends to move, against the market and on its own.
ASTS price history and drawdowns
ASTS's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Typical daily move of 2% or more ›
A typical daily move is 6.61% (the standard deviation of the last 30 daily returns).Recovered from its worst fall ›
The worst fall was 90.4%, from February 2021 to April 2024, regained by August 2024.Most 1-year holds ended higher ›
58% of 1-year holding periods in the last 7 years ended with a gain.Beat the S&P 500 since November 2019 ›
$10,000 invested in November 2019 is now worth $37,758, against $27,163 in the S&P 500 (SPY).
ASTS Drawdowns & Recovery
As of November 10, 2026, ASTS's worst peak-to-trough fall over the last 7 years was -90.4% (February 2021 to April 2024); it regained that peak by August 2024, 4 months after the low, and 58% of 1-year holding periods ended with a gain.
From weekly closing values. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into ASTS in November 2019 is worth now, against the same amount in the S&P 500.
Against the market: ASTS beat the S&P 500 over this period: $37,758 against $27,163.
A $10,000 investment in ASTS in November 2019 would be worth about $37,758 today, compared with about $27,163 for the same investment in the S&P 500 benchmark with its dividends reinvested.
Seasonal patterns
Which calendar months have been kind to ASTS, and which have not.
Strongest month, May: an average of +46.91%, up in 4 of 7 years.
Weakest month, April: an average of -18.19%, up in 1 of 7 years.
This month, November: has averaged +0.13%, up in 3 of 6 years. Past seasonality does not repeat on schedule.
Across 7 calendar years of history, ASTS's strongest calendar month has been May (average +46.91%, up in 4 of 7 years) and its weakest April (average -18.19%, up in 1 of 7 years).
Average return for each calendar month across 7 calendar years of history, from weekly closing prices.
ASTS stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in ASTS, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 7 years of price history, projects that a $10,000 investment in ASTS today could grow to about $14,843 by 2030 in the base case, with a 90th-percentile outcome near $53,469 and a 10th-percentile outcome around $4,120. Projections are statistical simulations, not guarantees.
ASTS Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $49.97 for ASTS by 2030 in the base case, from $33.67 today (1.5x over 4 years). The 10th-percentile path ends near $13.87. These are outcomes of a Monte Carlo simulation run on ASTS's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $19.58 | $37.16 | $70.54 | |
| 2028 | $16.57 | $41.02 | $102 | |
| 2029 | $14.92 | $45.28 | $137 | |
| 2030 | $13.87 | $49.97 | $180 |
Method: a lognormal simulation of ASTS's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. ASTS is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation. How the simulation works
ASTS insider trading
What the people running the company have bought and sold.
ASTS insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: Insiders bought $806K on the open market and sold $459.4M.
As of November 10, 2026, ASTS insiders reported 21 open-market sales worth $459.4M and 5 open-market purchases worth $806K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 16, 2026 | Huiwen Yao
Chief Technology Officer
|
Sell | 40.0K | $2.4M |
| Sep 16, 2026 | Shanti B. Gupta
Chief Operating Officer
|
Sell | 12.0K | $706.7K |
| Aug 31, 2026 | Adriana Cisneros
Director
|
Buy | 10.8K | $619.2K |
| Aug 19, 2026 | Huiwen Yao
Chief Technology Officer
|
Option | 40.0K | $2.6K |
| Aug 17, 2026 | Abel Antonio Avellan
Chief Executive Officer
|
Grant | 150.0K | - |
| Aug 17, 2026 | Maya Bernal
Officer
|
Grant | 20.0K | - |
| Aug 17, 2026 | Shanti B. Gupta
Chief Operating Officer
|
Grant | 75.0K | - |
| Aug 17, 2026 | Andrew Martin Johnson
Chief Financial Officer
|
Grant | 75.0K | - |
| Aug 17, 2026 | Scott Wisniewski
President
|
Grant | 75.0K | - |
| Jun 12, 2026 | Adriana Cisneros
Director
|
Grant | 2.1K | - |
| Jun 12, 2026 | Ronald L Rubin
Director
|
Grant | 2.1K | - |
| Jun 12, 2026 | Richard Sarnoff
Director
|
Grant | 2.1K | - |
| Jun 12, 2026 | Julio A Torres
Director
|
Grant | 2.1K | - |
| Jun 11, 2026 | Andrew Martin Johnson
Chief Financial Officer
|
Sell | 45.8K | $4.3M |
| Jun 5, 2026 | Huiwen Yao
Chief Technology Officer
|
Sell | 40.0K | $3.9M |
| May 22, 2026 | Huiwen Yao
Chief Technology Officer
|
Grant | 30.0K | - |
| May 20, 2026 | Andrew Martin Johnson
Chief Financial Officer
|
Sell | 5.0K | $451.3K |
| May 19, 2026 | Huiwen Yao
Chief Technology Officer
|
Option | 40.0K | $2.6K |
| May 18, 2026 | Shanti B. Gupta
Chief Operating Officer
|
Grant | 66.7K | - |
| May 13, 2026 | Julio A Torres
Director
|
Sell | 15.0K | $1.1M |
| Apr 15, 2026 | Hiroshi Mikitani
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 3.0M | $270.9M |
| Mar 24, 2026 | Abel Antonio Avellan
Chief Executive Officer
|
Grant | 184.4K | - |
| Mar 24, 2026 | Shanti B. Gupta
Chief Operating Officer
|
Grant | 54.7K | - |
| Mar 24, 2026 | Andrew Martin Johnson
Chief Financial Officer
|
Grant | 100.0K | - |
| Mar 24, 2026 | Scott Wisniewski
President
|
Grant | 123.4K | - |
| Mar 23, 2026 | Huiwen Yao
Chief Technology Officer
|
Sell | 40.0K | $3.6M |
| Mar 11, 2026 | Huiwen Yao
Chief Technology Officer
|
Option | 40.0K | $2.6K |
| Dec 24, 2025 | Keith R Larson
Director
|
Buy | 625 | $50.0K |
| Dec 17, 2025 | Keith R Larson
Director
|
Buy | 715 | $50.1K |
| Dec 10, 2025 | Shanti B. Gupta
Chief Operating Officer
|
Sell | 10.0K | $773.4K |
| Dec 10, 2025 | Keith R Larson
Director
|
Buy | 675 | $49.1K |
| Dec 9, 2025 | American Tower Corporation
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 2.3M | $159.6M |
| Dec 5, 2025 | Huiwen Yao
Chief Technology Officer
|
Sell | 40.0K | $2.9M |
| Dec 5, 2025 | Maya Bernal
Officer
|
Sell | 6.0K | $442.6K |
| Dec 2, 2025 | Abel Antonio Avellan
Chief Executive Officer
|
Grant | 250.0K | - |
| Dec 2, 2025 | Shanti B. Gupta
Chief Operating Officer
|
Grant | 125.0K | - |
| Dec 2, 2025 | Andrew Martin Johnson
Chief Financial Officer
|
Grant | 125.0K | - |
| Dec 2, 2025 | Scott Wisniewski
President
|
Grant | 125.0K | - |
| Nov 26, 2025 | Andrew Martin Johnson
Chief Financial Officer
|
Sell | 10.0K | $560.0K |
| Nov 20, 2025 | Adriana Cisneros
Director
|
Buy | 750 | $38.1K |
| Nov 14, 2025 | Huiwen Yao
Chief Technology Officer
|
Option | 40.0K | $2.6K |
| Sep 16, 2025 | Huiwen Yao
Chief Technology Officer
|
Sell | 40.0K | $1.6M |
| Sep 3, 2025 | Huiwen Yao
Chief Technology Officer
|
Sell | 16.0K | $768.6K |
| Sep 2, 2025 | Huiwen Yao
Chief Technology Officer
|
Option | 40.0K | $2.6K |
| Aug 26, 2025 | Andrew Martin Johnson
Chief Financial Officer
|
Sell | 20.0K | $1.0M |
| Aug 15, 2025 | Andrew Martin Johnson
Chief Financial Officer
|
Grant | 93.8K | - |
| Aug 15, 2025 | Scott Wisniewski
President
|
Grant | 93.8K | - |
| Jun 24, 2025 | Adriana Cisneros
Director
|
Grant | 801 | - |
| Jun 24, 2025 | Ronald L Rubin
Director
|
Grant | 801 | - |
| Jun 24, 2025 | Richard Sarnoff
Director
|
Grant | 801 | - |
| Jun 24, 2025 | Julio A Torres
Director
|
Grant | 801 | - |
| Jun 24, 2025 | Johan Wibergh
Director
|
Grant | 801 | - |
| Jun 16, 2025 | Shanti B. Gupta
Chief Operating Officer
|
Sell | 10.0K | $418.4K |
| Jun 10, 2025 | Huiwen Yao
Chief Technology Officer
|
Sell | 4.3K | $147.1K |
| Jun 9, 2025 | Scott Wisniewski
President
|
Sell | 50.0K | $1.8M |
| Jun 9, 2025 | Shanti B. Gupta
Chief Operating Officer
|
Sell | 15.0K | $541.2K |
| Jun 6, 2025 | Adriana Cisneros
Director
|
Grant | 4.8K | - |
| Jun 6, 2025 | Ronald L Rubin
Director
|
Grant | 4.8K | - |
| Jun 6, 2025 | Richard Sarnoff
Director
|
Grant | 4.8K | - |
| Jun 6, 2025 | Julio A Torres
Director
|
Grant | 4.8K | - |
| Jun 6, 2025 | Johan Wibergh
Director
|
Grant | 4.8K | - |
| Jun 2, 2025 | Huiwen Yao
Chief Technology Officer
|
Option | 25.0K | $603.8K |
| Jun 2, 2025 | Huiwen Yao
Chief Technology Officer
|
Grant | 25.0K | - |
| May 30, 2025 | Maya Bernal
Officer
|
Grant | 20.0K | - |
| May 16, 2025 | Huiwen Yao
Chief Technology Officer
|
Sell | 55.0K | $1.5M |
Source: TwelveData, from SEC Form 4 filings
ASTS stock forecast: questions people ask
Answered from the figures on this page, as of November 10, 2026.